Doxycycline to Treat Community-Acquired Pneumonia
- PMID: 35926091
- DOI: 10.1093/cid/ciac617
Doxycycline to Treat Community-Acquired Pneumonia
Keywords: community-acquired pneumonia; doxycycline; guidelines; pneumococcus.
Conflict of interest statement
Potential conflicts of interest. The author: No reported conflicts of interest. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment on
-
Efficacy of Doxycycline for Mild-to-Moderate Community-Acquired Pneumonia in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Clin Infect Dis. 2023 Feb 18;76(4):683-691. doi: 10.1093/cid/ciac615. Clin Infect Dis. 2023. PMID: 35903011
Similar articles
-
Treatment for community acquired pneumonia: more support for doxycycline.Arch Intern Med. 1999 Aug 9-23;159(15):1814-5. doi: 10.1001/archinte.159.15.1814. Arch Intern Med. 1999. PMID: 10448791 No abstract available.
-
Community acquired pneumonia.Aust Fam Physician. 2004 Aug;33(8):583; author reply 583. Aust Fam Physician. 2004. PMID: 15373373 No abstract available.
-
Doxycycline and community-acquired pneumonia.Am Fam Physician. 1998 Feb 1;57(3):426-7. Am Fam Physician. 1998. PMID: 9475892 No abstract available.
-
Outpatient management of community-acquired pneumonia.Hosp Pract (1995). 1998 Jun 15;33(6):123-33. doi: 10.1080/21548331.1998.11443708. Hosp Pract (1995). 1998. PMID: 9636355 Review.
-
Doxycycline or moxifloxacin for the management of community-acquired pneumonia in the UK?Int J Antimicrob Agents. 2008 Aug;32(2):101-5. doi: 10.1016/j.ijantimicag.2008.02.003. Epub 2008 Jun 20. Int J Antimicrob Agents. 2008. PMID: 18571380 Review.
Cited by
-
2022 - Pros and Cons in General Internal Medicine and Geriatrics.Acta Biomed. 2023 Feb 13;94(1):e2023063. doi: 10.23750/abm.v94i1.14226. Acta Biomed. 2023. PMID: 36786245 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
